loading...| Preferred Name |
besifloxacin |
|
| Synonyms |
7-(3-aminohexahydro-1H-azepin-1-yl)-8-chloro-1-cyclopropyl-6-fluoro-1,4-dihydro-4-oxo-3-quinolinecarboxylic acid |
|
| ID |
http://purl.bioontology.org/ontology/MESH/C522124 |
|
| altLabel |
7-(3-aminohexahydro-1H-azepin-1-yl)-8-chloro-1-cyclopropyl-6-fluoro-1,4-dihydro-4-oxo-3-quinolinecarboxylic acid 7-((3R)-aminohexahydro-1H-azepin-1-yl)-8-chloro-1-cyclopropyl-6-fluoro-1,4-dihydro-4-oxo-3-quinolinecarboxylic acid besivance besifloxacin hydrochloride BOL-303224-A |
|
| cui |
C2351042 C2710017 C2702050 C1959472 C3886519 |
|
| HM |
D001381 D024841 |
|
| Inverse of RB |
BFE2NBZ7NX 7506A6J57T 0 |
|
| isa | ||
| LT |
TRD |
|
| Mapped to | ||
| MDA |
20070817 |
|
| MeSH Frequency |
75 |
|
| MMR |
20180410 |
|
| notation |
C522124 |
|
| PA |
D059005 D000900 |
|
| prefLabel |
besifloxacin |
|
| RR |
7506A6J57T |
|
| SC |
1 |
|
| SRC |
J Ocul Pharmacol Ther. 2007 Jun;23(3):243-56 |
|
| TERMUI |
T000940970 T704222 T715281 T000867031 T704221 T000867029 |
|
| TH |
NLM (2008) FDA SRS (2013) FDA SRS (2017) USAN (19XX) INN (19XX) NLM (2017) NLM (2007) NLM (2014) |
|
| tui |
T109 T195 T121 |